$334 Million is the total value of Integral Health Asset Management, LLC's 60 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 96.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LHCG | Buy | LHC GROUP INC | $21,790,000 | +210.8% | 125,000 | +150.0% | 6.52% | +111.3% |
| DGX | QUEST DIAGNOSTICS INC | $13,675,000 | +41.9% | 120,000 | 0.0% | 4.10% | -3.5% | |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $11,760,000 | +20.6% | 200,000 | +14.3% | 3.52% | -18.0% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $11,016,000 | +138.4% | 175,000 | +59.1% | 3.30% | +62.1% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $9,867,000 | +6.2% | 80,000 | -27.3% | 2.96% | -27.8% |
| CRL | New | CHARLES RIV LABS INTL INC | $9,589,000 | – | 55,000 | +100.0% | 2.87% | – |
| GWPH | GW PHARMACEUTICALS PLCads | $9,204,000 | +40.1% | 75,000 | 0.0% | 2.76% | -4.7% | |
| ABC | New | AMERISOURCEBERGEN CORP | $9,069,000 | – | 90,000 | +100.0% | 2.72% | – |
| NVRO | Buy | NEVRO CORP | $8,960,000 | +124.1% | 75,000 | +87.5% | 2.68% | +52.4% |
| CCXI | Sell | CHEMOCENTRYX INC | $8,631,000 | +13.1% | 150,000 | -21.1% | 2.58% | -23.1% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $8,580,000 | +144.5% | 110,000 | +83.3% | 2.57% | +66.2% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $8,108,000 | +66.1% | 195,000 | +14.7% | 2.43% | +12.9% |
| AGIO | AGIOS PHARMACEUTICALS INC | $8,022,000 | +50.7% | 150,000 | 0.0% | 2.40% | +2.5% | |
| CYTK | Buy | CYTOKINETICS INC | $8,014,000 | +112.4% | 340,000 | +6.2% | 2.40% | +44.4% |
| DHR | Sell | DANAHER CORPORATION | $7,957,000 | +15.0% | 45,000 | -10.0% | 2.38% | -21.8% |
| HUM | Buy | HUMANA INC | $7,755,000 | +393.9% | 20,000 | +300.0% | 2.32% | +235.5% |
| SGEN | New | SEATTLE GENETICS INC | $7,646,000 | – | 45,000 | +100.0% | 2.29% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $7,484,000 | – | 12,000 | +100.0% | 2.24% | – |
| CTLT | Sell | CATALENT INC | $7,330,000 | -5.9% | 100,000 | -33.3% | 2.20% | -36.1% |
| MOH | New | MOLINA HEALTHCARE INC | $7,119,000 | – | 40,000 | +100.0% | 2.13% | – |
| NUVA | New | NUVASIVE INC | $6,958,000 | – | 125,000 | +100.0% | 2.08% | – |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $6,611,000 | -22.1% | 125,000 | -34.2% | 1.98% | -47.0% |
| DXCM | New | DEXCOM INC | $6,081,000 | – | 15,000 | +100.0% | 1.82% | – |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $6,038,000 | – | 65,000 | +100.0% | 1.81% | – |
| AMGN | New | AMGEN INC | $5,897,000 | – | 25,000 | +100.0% | 1.77% | – |
| MRK | Sell | MERCK & CO. INC | $5,800,000 | -42.0% | 75,000 | -42.3% | 1.74% | -60.6% |
| LLY | New | LILLY ELI & CO | $5,746,000 | – | 35,000 | +100.0% | 1.72% | – |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $5,709,000 | +85.7% | 50,000 | +25.0% | 1.71% | +26.3% |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $4,991,000 | – | 150,000 | +100.0% | 1.50% | – |
| EXAS | Sell | EXACT SCIENCES CORP | $4,782,000 | +3.1% | 55,000 | -31.2% | 1.43% | -29.9% |
| ABT | Buy | ABBOTT LABS | $4,572,000 | +28.8% | 50,000 | +11.1% | 1.37% | -12.5% |
| HZNP | New | HORIZON THERAPEUTICS PUB LTD | $4,446,000 | – | 80,000 | +100.0% | 1.33% | – |
| BAX | New | BAXTER INTL INC | $4,305,000 | – | 50,000 | +100.0% | 1.29% | – |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $4,178,000 | – | 35,000 | +100.0% | 1.25% | – |
| MCK | MCKESSON CORP | $3,836,000 | +13.4% | 25,000 | 0.0% | 1.15% | -22.9% | |
| NVST | New | ENVISTA HOLDINGS CORPORATION | $3,691,000 | – | 175,000 | +100.0% | 1.10% | – |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $3,619,000 | +302.1% | 135,000 | +170.0% | 1.08% | +173.7% |
| EXEL | EXELIXIS INC | $3,561,000 | +37.9% | 150,000 | 0.0% | 1.07% | -6.3% | |
| GOSS | New | GOSSAMER BIO INC | $3,510,000 | – | 270,000 | +100.0% | 1.05% | – |
| PODD | New | INSULET CORP | $3,497,000 | – | 18,000 | +100.0% | 1.05% | – |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $3,395,000 | +123.9% | 250,000 | +25.0% | 1.02% | +52.2% |
| New | MODERNA INCput | $3,211,000 | – | 50,000 | +100.0% | 0.96% | – | |
| DNLI | Buy | DENALI THERAPEUTICS INC | $3,143,000 | +99.4% | 130,000 | +44.4% | 0.94% | +35.6% |
| PKI | Sell | PERKINELMER INC | $2,943,000 | -13.1% | 30,000 | -33.3% | 0.88% | -41.0% |
| CHNG | New | CHANGE HEALTHCARE INC | $2,800,000 | – | 250,000 | +100.0% | 0.84% | – |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $2,794,000 | -17.8% | 110,000 | -40.5% | 0.84% | -44.1% |
| New | INTRA CELLULAR THERAPIES INCcall | $2,567,000 | – | 100,000 | +100.0% | 0.77% | – | |
| ABBV | New | ABBVIE INC | $2,455,000 | – | 25,000 | +100.0% | 0.74% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $2,440,000 | – | 20,000 | +100.0% | 0.73% | – |
| ZGNX | New | ZOGENIX INC | $2,431,000 | – | 90,000 | +100.0% | 0.73% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $2,422,000 | – | 350,000 | +100.0% | 0.72% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $2,402,000 | +13.8% | 70,000 | -26.3% | 0.72% | -22.6% |
| MGNX | New | MACROGENICS INC | $1,954,000 | – | 70,000 | +100.0% | 0.58% | – |
| BGNE | New | BEIGENE LTDsponsored adr | $1,884,000 | – | 10,000 | +100.0% | 0.56% | – |
| WBA | Sell | WALGREENS BOOTS ALLIANCE INC | $1,696,000 | -53.7% | 40,000 | -50.0% | 0.51% | -68.5% |
| PTCT | New | PTC THERAPEUTICS INC | $1,522,000 | – | 30,000 | +100.0% | 0.46% | – |
| GNMK | New | GENMARK DIAGNOSTICS INC | $1,471,000 | – | 100,000 | +100.0% | 0.44% | – |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $1,421,000 | -26.0% | 75,000 | -25.0% | 0.43% | -49.6% |
| INCY | New | INCYTE CORP | $1,040,000 | – | 10,000 | +100.0% | 0.31% | – |
| BMYRT | Sell | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $537,000 | -68.6% | 150,000 | -66.7% | 0.16% | -78.6% |
| PFNX | Exit | PFENEX INC | $0 | – | -85,000 | -100.0% | -0.33% | – |
| Exit | AMARIN CORP PLC | $0 | – | -200,000 | -100.0% | -0.35% | – | |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -0.56% | – |
| NERV | Exit | MINERVA NEUROSCIENCES INC | $0 | – | -250,000 | -100.0% | -0.66% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -40,000 | -100.0% | -0.71% | – |
| Exit | EXELIXIS INC | $0 | – | -100,000 | -100.0% | -0.76% | – | |
| ALKS | Exit | ALKERMES PLC | $0 | – | -150,000 | -100.0% | -0.95% | – |
| TXG | Exit | 10X GENOMICS INC | $0 | – | -40,000 | -100.0% | -1.10% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -10,000 | -100.0% | -1.10% | – |
| NVO | Exit | NOVO-NORDISK A Sadr | $0 | – | -55,000 | -100.0% | -1.46% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -7,000 | -100.0% | -1.53% | – |
| CHWY | Exit | CHEWY INCcl a | $0 | – | -100,000 | -100.0% | -1.65% | – |
| XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -100,000 | -100.0% | -1.71% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -125,000 | -100.0% | -1.80% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -25,000 | -100.0% | -2.53% | – |
| NVS | Exit | NOVARTIS A Gsponsored adr | $0 | – | -70,000 | -100.0% | -2.54% | – |
| MASI | Exit | MASIMO CORP | $0 | – | -35,000 | -100.0% | -2.73% | – |
| EHC | Exit | ENCOMPASS HEALTH CORP | $0 | – | -115,000 | -100.0% | -3.24% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -170,000 | -100.0% | -4.45% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -115,000 | -100.0% | -4.57% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.